Abivax to Participate in Upcoming Investor Conferences
Abivax has announced its scheduled participation in several investor conferences taking place this autumn.
Stocks · News reference
Earnings Scheduled For September 21, 2026
Companies Reporting Before The Bell • Ennis (NYSE:EBF) is expected to report earnings for its second quarter. Companies Reporting After The Bell • Abivax (NASDAQ:ABVX) is projected to report quarterly loss at $1.08 per
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Ennis, Inc. Acquires Telemark Diversified Graphics
Ennis, Inc. has acquired Sturgis, Michigan-based thermal paper products manufacturer Telemark Diversified Graphics to expand its product offerings and manufacturing capabilities.
Abivax shares are trading higher after Guggenheim reiterated its Buy rating on the stock and maintained a $175 price target.
Guggenheim Reiterates Buy on Abivax, Maintains $175 Price Target
Guggenheim analyst Yatin Suneja reiterates Abivax (NASDAQ:ABVX) with a Buy and maintains $175 price target.
Abivax To Present Seven Scientific Abstracts On Obefazimod, Lead Drug Candidate For Treatment Of Active Ulcerative Colitis At UEG Week 2026 Meeting
BTIG Reiterates Buy on Abivax, Maintains $175 Price Target
BTIG analyst Julian Harrison reiterates Abivax (NASDAQ:ABVX) with a Buy and maintains $175 price target.